Imidazo [1, 2-A] pyridine derivatives useful as ALK inhibitors

Details for Australian Patent Application No. 2008313773 (hide)

International Classifications

Event Publications

15 April 2010 PCT application entered the National Phase

PCT publication WO2009/050183 Priority application(s): WO2009/050183

29 April 2010 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name Novartis AG, Application No. 2008313773, under INID (54) correct the title to read Imidazo [1, 2-A] pyridine derivatives useful as ALK inhibitors.

12 April 2012 Application Accepted

Published as AU-B-2008313773

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.